InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Kuriakose Emil. Director active across 2 companies, notably Calithera Biosciences, Inc.. Cumulatively, 11 reports have been published. Split: 0 buy · 6 sells. Total volume traded: €86k. Activity tracked since 5 November 2021. The latest transaction was filed on 1 April 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations
Kuriakose Emil is a declarant linked to Terns Pharmaceuticals, Inc. and Calithera Biosciences, Inc., with the listed role of Chief Medical Officer and CHIEF MEDICAL OFFICER. Across 11 filings, the 11 sampled filings run from 2021-11-09 to 2026-04-02 and show only sales, with sum_sell_eur of 85937 and sum_buy_eur of 0, and the transaction nature listed as Cession.